Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Parkinson's Disease

  Free Subscription


25.03.2024

1 Ann Neurol
1 Exp Brain Res
1 Int J Neurosci
2 Lancet Neurol
1 Neurochem Res
2 Neurology
1 Neurosci Lett
1 PLoS One
1 Rev Neurol (Paris)


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Neurol

  1. DEL BENE VA, Martin RC, Brinkerhoff SA, Olson JW, et al
    Differential Cognitive Effects of Unilateral Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease.
    Ann Neurol. 2024 Mar 19. doi: 10.1002/ana.26903.
    PubMed         Abstract available


    Exp Brain Res

  2. LOPES-SILVA LB, Cunha DMG, Lima AC, Bioni VS, et al
    Sleep deprivation induces late deleterious effects in a pharmacological model of Parkinsonism.
    Exp Brain Res. 2024 Mar 18. doi: 10.1007/s00221-024-06811.
    PubMed         Abstract available


    Int J Neurosci

  3. ATWAN H, Ch MBB, Abdelaziz A, Ch MBB, et al
    Median nerve ultrasonography in Parkinson's disease: A Systematic Review and Meta-analysis.
    Int J Neurosci. 2024 Mar 18:1-11. doi: 10.1080/00207454.2024.2327407.
    PubMed         Abstract available


    Lancet Neurol

  4. CARDOSO F, Tolosa E
    Fluctuations in Parkinson's disease: progress and challenges.
    Lancet Neurol. 2024 Mar 15:S1474-4422(24)00116.
    PubMed        

  5. ESPAY AJ, Stocchi F, Pahwa R, Albanese A, et al
    Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial.
    Lancet Neurol. 2024 Mar 15:S1474-4422(24)00052.
    PubMed         Abstract available


    Neurochem Res

  6. KRYL'SKII ED, Razuvaev GA, Popova TN, Oleinik SA, et al
    6-Hydroxy-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline Demonstrates Neuroprotective Properties in Experimental Parkinson's Disease by Enhancing the Antioxidant System, Normalising Chaperone Activity and Suppressing Apoptosis.
    Neurochem Res. 2024 Mar 19. doi: 10.1007/s11064-024-04125.
    PubMed         Abstract available


    Neurology

  7. BROWN G, De Jesus S
    Bridging the Gap: Local Field Potentials Offer a Peek Into the Brain of a Person With Parkinson Disease.
    Neurology. 2024;102:e209283.
    PubMed         Abstract available

  8. ZHAO Y, Lai Y, Konijnenberg H, Huerta JM, et al
    Association of Coffee Consumption and Prediagnostic Caffeine Metabolites With Incident Parkinson Disease in a Population-Based Cohort.
    Neurology. 2024;102:e209201.
    PubMed         Abstract available


    Neurosci Lett

  9. LI Z, Liu J, Miao X, Ge S, et al
    Reorganization of structural brain networks in Parkinson's disease with postural instability/gait difficulty.
    Neurosci Lett. 2024 Mar 19:137736. doi: 10.1016/j.neulet.2024.137736.
    PubMed         Abstract available


    PLoS One

  10. SCHRAG A, Kostev K
    Association of antihypertensives and Parkinson's disease in a primary care population matched for underlying diagnosis.
    PLoS One. 2024;19:e0299985.
    PubMed         Abstract available


    Rev Neurol (Paris)

  11. SINGLAS M, Tran THC, Boucenna W, Diouf M, et al
    Is internal retinal thickness an early marker of Alzheimer's and Lewy body diseases?
    Rev Neurol (Paris). 2023 Nov 2:S0035-3787(23)01081.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.